Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Unknown 3Not yet recruiting 1Completed 1

Sponsor Class

OTHER 218INDUSTRY 27NIH 7OTHER_GOV 5NETWORK 2

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Thoracic 1Plasma cell 1Gynecologic 1

Conditions

Breast Neoplasms 267Neoplasms 177Colorectal Neoplasms 133Stomach Neoplasms 107Uterine Cervical Neoplasms 96Carcinoma, Non-Small-Cell Lung 89Prostatic Neoplasms 83Lung Neoplasms 78Carcinoma, Hepatocellular 73Rectal Neoplasms 64Ovarian Neoplasms 54Esophageal Neoplasms 53Pancreatic Neoplasms 52Colonic Neoplasms 52Recurrence 43Multiple Myeloma 39Neoplasm Metastasis 38Head and Neck Neoplasms 37Endometrial Neoplasms 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Motor Activity 34Melanoma 33Polycystic Ovary Syndrome 32Lymphoma 32Urinary Bladder Neoplasms 31Leukemia, Myeloid, Acute 30Thyroid Neoplasms 29Small Cell Lung Carcinoma 28Nasopharyngeal Carcinoma 25Lymphoma, Non-Hodgkin 25

Interventions

Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER_GOV × Neoplasm, Residual × Clear all
NCT06854939 2025-03-03

MRDSEEKER

National Cancer Center, Japan

Not yet recruiting
350 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm, Residual

NCT05697913 2024-03-06

Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation

Hospital Galdakao-Usansolo

Phase NA Unknown
66 enrolled
Plasma cell

Multiple Myeloma, Neoplasm, Residual

NCT05137860 2022-01-18

Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD

Hospital General de Mexico

Phase 4 Unknown
56 enrolled
LymphoidOther hematologic neoplasm

Recurrence, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03788850 2020-08-27

FARDCC

National Institute of Cancerología

Completed
397 enrolled
Gynecologic

Uterine Cervical Dysplasia, Neoplasm, Residual

NCT03413046 2018-01-29

The Effect of Chemotherapy on Regulatory T Cells

Ankara Children's Health and Diseases Hematology and Oncology Training and Research Hospital

Unknown
60 enrolled
LymphoidOther hematologic neoplasm

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡